HRMY Earnings

Quarterly EPS
$0.81
Q3 2024
$0.87
Q4 2024
$0.79
Q1 2025
$0.69
Q2 2025
$0.88
Q3 2025
$0.39
Q4 2025
$0.56
Q1 2026
$1.30
Q2 2026
Latest Revenue261.3M
Latest Net Income75.4M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$1.30261.3M75.4M+30.3%+88.4%
Q1 2026$0.56215.4M32.5M+16.6%-29.1%
Q4 2025$0.39243.8M22.5M+21.1%-55.2%
Q3 2025$0.88239.5M50.9M+28.7%+8.6%
Q2 2025$0.69200.5M39.8M+16.0%+245.0%
Q1 2025$0.79184.7M45.6M+19.5%+16.2%
Q4 2024$0.87201.3M49.5M+19.5%+89.1%
Q3 2024$0.81186.0M46.1M+16.1%+26.6%
Q2 2024$0.20172.8M11.6M
Q1 2024$0.68154.6M38.3M
Q4 2023$0.46168.4M26.6M
Q3 2023$0.64160.3M38.5M
Harmony Biosciences (HRMY) — Earnings